TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference
TELA Bio (NASDAQ: TELA), a medical technology company specializing in soft-tissue reconstruction solutions, has announced its participation in the 2025 Jefferies Global Healthcare Conference. The company's management team will deliver a presentation on June 5th, 2025, at 11:05 am ET. Investors and interested parties can access both the live presentation and archived webcast through the company's investor relations website at ir.telabio.com.
TELA Bio (NASDAQ: TELA), un'azienda di tecnologia medica specializzata in soluzioni per la ricostruzione dei tessuti molli, ha annunciato la sua partecipazione alla Jefferies Global Healthcare Conference 2025. Il team di gestione dell'azienda terrà una presentazione il 5 giugno 2025 alle 11:05 ET. Investitori e interessati potranno seguire sia la presentazione in diretta sia la registrazione disponibile sul sito web delle relazioni con gli investitori dell'azienda all'indirizzo ir.telabio.com.
TELA Bio (NASDAQ: TELA), una empresa de tecnología médica especializada en soluciones para la reconstrucción de tejidos blandos, ha anunciado su participación en la Conferencia Global de Salud Jefferies 2025. El equipo directivo de la compañía realizará una presentación el 5 de junio de 2025 a las 11:05 am ET. Los inversores y partes interesadas podrán acceder tanto a la presentación en vivo como a la transmisión archivada a través del sitio web de relaciones con inversores de la compañía en ir.telabio.com.
TELA Bio (NASDAQ: TELA)는 연조직 재건 솔루션을 전문으로 하는 의료기술 회사로, 2025 Jefferies 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사 경영진은 2025년 6월 5일 오전 11시 05분(동부시간)에 프레젠테이션을 진행할 예정입니다. 투자자 및 관심 있는 분들은 회사 투자자 관계 웹사이트 ir.telabio.com에서 생중계와 녹화된 웹캐스트를 모두 시청할 수 있습니다.
TELA Bio (NASDAQ : TELA), une entreprise de technologie médicale spécialisée dans les solutions de reconstruction des tissus mous, a annoncé sa participation à la Jefferies Global Healthcare Conference 2025. L'équipe de direction de la société présentera le 5 juin 2025 à 11h05 ET. Les investisseurs et les parties intéressées pourront accéder à la fois à la présentation en direct et au webinaire archivé via le site des relations investisseurs de la société à l'adresse ir.telabio.com.
TELA Bio (NASDAQ: TELA), ein Medizintechnikunternehmen, das sich auf Lösungen für die Rekonstruktion von Weichgewebe spezialisiert hat, hat seine Teilnahme an der Jefferies Global Healthcare Conference 2025 angekündigt. Das Management-Team des Unternehmens wird am 5. Juni 2025 um 11:05 Uhr ET eine Präsentation halten. Investoren und Interessierte können sowohl die Live-Präsentation als auch das Archiv-Webcast über die Investor-Relations-Website des Unternehmens unter ir.telabio.com verfolgen.
- None.
- None.
MALVERN, Pa., May 22, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the 2025 Jefferies Global Healthcare Conference.
TELA’s management is scheduled to present at the 2025 Jefferies Global Healthcare Conference at 11:05 am ET on June 5th, 2025. Interested parties can access the live and archived webcast at ir.telabio.com.
About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.
Investor Contact
Louisa Smith
ir@telabio.com
